Current Issue: December 2018
Insulin receptor signaling provides a possible target to boost protection for patients with diabetes and prediabetes. People with diabetes or prediabetes suffer more and harsher urinary tract infections than the general population.
Spotlight shone on wide range of discoveries, new insights and ways to diagnose, treat and prevent disease and harm. More than 500 Nationwide Children’s Hospital faculty, staff and trainees — a record number — attended the 2018 Research Retreat, which showcased the expanse of
A new mouse model of facioscapulohumeral muscular dystrophy (FSHD) reflects many disease characteristics and appears to be useful for testing therapeutics. DUX4, the protein responsible for the disease, is so potent that making a model has been challenging. The lab of Scott Harper, PhD, a principal investigator in the Center for Gene Therapy, reports their model produces controllable amounts of DUX4 when the mouse is fed the drug tamoxifen. In tests, the model built muscle mass and strength when treated with the gene AAV1.Follistatin. The findings are published in JCI Insight.
Alvarez-Perea A, Sánchez-García S, Muñoz Cano R, Antolín-Amérigo D, Tsilochristou O, Stukus DR. Impact of eHealth in Allergic Diseases and Allergic Patients. J Investig Allergol Clin Immunol. 2018 Nov 20:0. doi: 10.18176/jiaci.0354. [Epub ahead of print] Review.